Reimbursement Coding & Strategy Director
bioMérieux
Summary
The Reimbursement Coding and Strategy Director leads the development and execution of U.S. coding strategies for new and existing in vitro diagnostic products. The role assesses coding pathways and gaps, defines evidence and documentation requirements, and integrates coding considerations into product development, launch readiness, and lifecycle planning.
Job description
Coding Strategy and Pathway Development
- Lead the development of U.S. coding strategies for pipeline, launch, and on-market diagnostic products.
- Assess available coding pathways, including CPT, PLA, HCPCS, and ICD-10 considerations, and recommend the pathway that best supports the intended use, site of service, and reimbursement objective.
- Identify coding gaps, risks, dependencies, and decision points early in product development and translate findings into actionable recommendations for governance and product teams.
- Develop long-range coding roadmaps, including key milestones, evidence needs, submission timing, ownership, and contingency approaches.
- Evaluate when existing codes may be appropriate and when a new or revised code may be needed, documenting the rationale, business impact, and implementation considerations.
- Adjust coding strategies for existing products in response to product changes, utilization patterns, coding updates, or reimbursement barriers.
Coding Applications, Evidence, and Documentation
- Lead or coordinate the preparation of coding applications, supporting narratives, technical documentation, and evidence packages in partnership with Government Affairs, Medical Affairs, Regulatory Affairs, HEOR, and other subject-matter experts.
- Define the clinical, technical, utilization, and economic evidence needed to support coding objectives and incorporate those requirements into evidence-generation plans.
- Ensure coding submissions and supporting materials accurately reflect product characteristics, intended use, clinical utility, and the applicable diagnostic pathway.
- Maintain a centralized record of coding decisions, assumptions, submission history, status, risks, and outcomes to support continuity and organizational learning.
- Coordinate internal review and approval of coding materials in accordance with company requirements and applicable standards.
- Represent and attend AMA, ADLM, ACLA, CAP, AMP.
Product Development and Launch Integration
- Represent Market Access and coding strategy in U.S. go-to-market, pipeline, and lifecycle governance processes.
- Integrate coding considerations into product profiles, evidence plans, launch sequencing, pricing and reimbursement planning, and commercial readiness activities.
- Provide U.S. coding insights to global teams and adapt global market access tools to address U.S. coding requirements.
- Partner with brand and commercial teams to develop coding-related launch plans, customer resources, internal training, and objection-handling tools.
- Assess the operational implications of coding decisions for laboratories, providers, revenue cycle teams, sales teams, and customer support functions.
Coding Intelligence, Governance, and Enablement
- Monitor coding publications, code-set updates, application cycles, and industry developments that may affect pipeline or on-market products.
- Analyze potential business and access impact, communicate findings to relevant stakeholders, and recommend response plans.
- Establish coding governance tools, decision frameworks, standard operating practices, and performance measures to improve consistency and execution.
- Develop and maintain approved coding guides, reimbursement resources, training materials, and internal reference tools.
- Serve as an internal expert and educator on diagnostic coding concepts, pathways, limitations, and appropriate use of coding information.
- Collect field and customer insights related to coding barriers and use those insights to refine product-level strategies and close access gaps.
- Perform all work in compliance with company quality procedures and standards.
Requirements
- Bachelor's degree in Health Policy, Political Science, Life Sciences, Law, Public Health, Economics or Business
- Advanced degree preferred (e.g., MBA, MPH)
- 7+ years of healthcare experience in clinical laboratory and/or biotechnology industries
- 3+ years of Medicare Policy experience
- Diagnostic or Medical Devices experience preferred
- Familiarity with diagnostic technologies utilized in the laboratory setting, regulatory impacts, commercialization, and reimbursement considerations
- Demonstrated knowledge and experience of the U.S. healthcare policy and market access landscape
- Proven track record in building relationships and advocating for policy changes
- Strong strategy, innovation, collaboration, and analytical skills
- Strong communicator able to lead delivery and creation of innovative and tailored communications
- Deep understanding of the US Market Access environment (e.g., U.S. payer system, coding, payment, coverage and stakeholder engagement)
- Demonstrated ability to work both independently and interdependently in cross-functional (matrix) teams
- Proactive, self-motivated, and aware of larger business needs/implications
- Capable of prioritizing multiple priorities, model leadership behaviors, and create partnership across functions
- Highest standards of ethics and integrity
Benefits
- Medical, Dental & Vision
- Telemedicine
- Life & AD&D Insurance
- Short & Long-Term Disability
- 401(k) Matching
- Adoption Assistance
- Wellness Programs
- Employee Assistance Program
- Commuter Benefits
- Parental Leave
- Discount Programs
Company overview
bioMérieux is a world leader in the field of in vitro diagnostics, founded in 1963 as a family-owned company based in Marcy-l'Étoile, France. With over 10,000 employees spread across 45 countries and serving 160 countries through an extensive distribution network, the company specializes in developing innovative diagnostic solutions for both clinical and industrial applications. Their clinical diagnostics help healthcare professionals quickly identify pathologies and contamination sources, while their industrial solutions assist manufacturers in meeting stringent quality and safety standards for food and pharmaceutical products. bioMérieux focuses on three key areas of in vitro diagnostics: microbiology (where they are the world leader), immunoassays for high medical value tests, and molecular biology for syndromic diagnosis of infectious diseases. The company is particularly committed to combating antimicrobial resistance (AMR), with three-quarters of their R&D and 80% of their product portfolio dedicated to this critical public health challenge. They also provide comprehensive solutions for sepsis diagnosis and management, as well as diagnostic tools for acute non-infectious conditions like cardiovascular and kidney diseases.